• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Change Country
    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

Product

Product
Imaging
Bone & Metabolic Health Computed Tomography Fluoroscopy Interventional Guided Systems Magnetic Resonance Imaging Mammography Molecular Imaging Radiography (X-ray) Surgical Imaging All Imaging
Ultrasound
LOGIQ General Imaging Point of Care Versana Primary Care Vscan Air Handheld Vivid Cardiovascular Voluson Women's Health Verisound Ultrasound Digital Solutions All Ultrasound
Anaesthesia Delivery
Diagnostic Cardiology
Diagnostic ECG
Maternal & Infant Care
Patient Monitoring
Pharmaceutical Imaging Agents
Contrast Media Nuclear Imaging Agents
Healthcare IT
Advanced Visualization Hospital Operations | Command Center All Digital Solutions
Parts and Accessories
Clinical Accessories Imaging Accessories Service Shop

Services

Services
MyGEHealthcare Account
Healthcare Technology Management
Clinical Network Solutions
Service Shop

Support

Support
Education
Healthcare Learning System
Support and Documentation
Cleaner and Disinfectant Compatibility Disinfection of Ultrasound Probes Interoperability
Contact

Specialities

Specialities
Cardiology
Oncology

Insights

Insights
Insights Home
Docuseries
Thought Leadership
Podcasts

Shop

Shop
Vscan Handheld Ultrasound
Vscan Air CL Vscan Air SL
Service Shop
Accessories & Supplies
Shop All

About Us

About Us
Careers
About Us
Contact
Suppliers
Products
/
Colorectal Cancer
Colorectal Cancer
Oncology Solutions

The Patient Journey

 

The global burden of colorectal cancer (CRC) is expected to increase by 60 percent to more than 2.2 million new cases and 1.1 million deaths by 2030.1 Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. While the participation rates in screening are increasing, one quarter of the adults aged 50 to 75 years have never been screened.2 The five-year survival rate for colon cancer found at the local stage is 90 percent, highlighting the benefits of early detection.3

Diagnosis

Card Image

SIGNA™ Architect AIR™ Edition

Our premium 3.0T, 70 cm wide bore MRI system leverages intelligent technology to enable patient-friendly exams with exceptional image quality.

Card Image

PET/CT

The true potential of PET/CT is its ability to enable a true discovery.

Staging

Card Image

Computed Tomography

Your need for quality patient care at low dose with greater productivity and affordability is more important than ever.  That’s why we design CT syst...

Card Image

SIGNA™ PETMR with QuantWorks

Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.

Card Image

PET/CT

The true potential of PET/CT is its ability to enable a true discovery.

Treatment Planning

Card Image

Discovery RT

Discovery RT is a comprehensive radiation therapy solution that allows you to see all that your CT can see.

Card Image

OEC Elite CFD

The OEC Elite CFD offers stunning image clarity and detail at low dose with enhancements for an easy and efficient experience.

Card Image

Q.Clear

Do you know your patient’s response score? Q.Clear delivers quantitative SUV you and your patients can trust.

Card Image

PET/CT

The true potential of PET/CT is its ability to enable a true discovery.

Follow up

Card Image

SIGNA™ PETMR with QuantWorks

Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.

Card Image

Q.Clear

Do you know your patient’s response score? Q.Clear delivers quantitative SUV you and your patients can trust.

Card Image

PET/CT

The true potential of PET/CT is its ability to enable a true discovery.

Scan images of lungs, brain and heart.

The latest in Oncology

INSIGHTS

References:

1. Global patterns and trends in colorectal cancer incidence and mortality. Melina Arnold1, Mónica S Sierra1, Mathieu Laversanne1, Isabelle oerjomataram1, Ahmedin Jemal2, Freddie Bray1. Arnold M, et al. Gut 2017;66:683–691. doi:10.1136/gutjnl-2015-310912 683


2.https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/colorectal-cancer-screening2?ds=1&s=colorectal cancer


3. https://www.gastroconsa.com/colon-cancer-statistics/

JB04823XX